Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Diageo plc (DEO) vs Revvity Inc (RVTY) Price & Performance

Diageo plcTrade
Revvity IncTrade

Price performance (Past 24H)

Key statistics

Diageo plc vs Revvity Inc — how do they compare? Diageo plc trades at $94.95 (market cap $53.05B), while Revvity Inc trades at $117.6 (market cap $12.91B). The key difference: Diageo plc is far larger — about 4.1× Revvity Inc's market cap, and Diageo plc pays the higher dividend (3.5%). Which is the better fit depends on your goals.

DEORVTY
Market Cap
$53.05B$12.91B
Sector
TechnologyTechnology
52-Week High
$115.33$117.75
52-Week Low
$72.47$82.26
Enterprise Value
$72.54B$15.23B
Dividend Yield
3.5%0.24%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Diageo plc

Diageo (DEO) trades at $93.96, down 3.24% today, with mixed technical signals showing bullish moving averages but overbought RSI readings. The company reported FY2026 results with organic sales declining 2% but operating profit increasing 2% through cost savings. Recent news highlights a $1 billion cost-cutting plan and strategic reset under new CEO Dave Lewis, driving investor optimism despite North American weakness.

The outlook remains cautiously optimistic with analyst consensus leaning buy (49%) as cost savings and cash generation initiatives offset regional challenges. Key risks include persistent North American sales pressure and execution risks on the turnaround plan, while valuation metrics suggest premium pricing relative to historical levels.

Revvity Inc

RVTY trades at $117.88, up 1.6% today, with a bullish technical outlook and strong earnings momentum after beating Q2 2026 EPS estimates. The stock is near the consensus price target of $120.50, supported by a 51.72% analyst buy rating. Recent news highlights product launches like the SuperFlex prenatal system and investor conference participation, reinforcing growth prospects in diagnostics and biotech tools.

The outlook remains positive with revenue stability and margin strength, but elevated P/E of 55.64 poses valuation risk. Key opportunities include diagnostic demand and AI-driven workflows, while risks involve competitive pressures and execution challenges. Net cash flow turned positive in 2026, signaling improved financial health.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Diageo plc

Diageo is a global leader in beverage alcohol with an outstanding collection of brands including Johnnie Walker, Smirnoff, and Guinness. It operates a vast portfolio of spirits and beers across more than 180 countries.

Read more on DEO

About Revvity Inc

Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.

Read more on RVTY